Other Potential Indications

Other Potential Indications

In preclinical studies, Plinabulin has shown favorable safety and anti-tumor activity in a variety of cancer models, including brain tumors and KRAS mutant tumors. BeyondSpring believes that Plinabulin may also hold the potential to demonstrate efficacy across a broader spectrum of cancers, including gastrointestinal, breast, ovarian, prostate and hematological cancers.